Tong Zou
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Tong Zou has a total of 128 co-authors. Here are the top co-authors by number of shared publications:
Jia Wang
Department of Cardiology, Beijing Hospital, National Center for Gerontology, National Clinical Research Center for Gerontology, The Key Laboratory of Geriatrics of NHC, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China
9 shared publications- Jiefu Yang
Department of Cardiology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, People’s Republic of China
7 shared publications Shuhui Shen
Department of Cardiology, Beijing Hospital, National Center for Gerontology, National Clinical Research Center for Gerontology, The Key Laboratory of Geriatrics of NHC, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China
6 shared publicationsDonghao Liu
Department of Cardiology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, People’s Republic of China
5 shared publicationsYuqing Tian
Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, People’s Republic of China
5 shared publicationsBeibei Wang
Department of Cardiology, The First People’s Hospital of Jinzhong, Jinzhong, China
4 shared publications
Latest Publications
- 20 November 2026
- Published by Wiley in Advanced Materials
Buckled Silver Microflake Conductors With In Situ‐Generated Ag–O Coordination Enable 3D‐Printed Stretchable Cardiac Bioelectrodes
Metallic pacemaker electrodes risk myocardial injury during implantation, while silver micro‐flakes (AgMFs), despite excellent conductivity, are too rigid for stretchable devices without proper composite/device engineering. Here, we present a synergistic strategy to fabricate fully stretchable, electrically stable, and crack‐resistant cardiac electrodes by integrating AgMF‐based ink with metal‐organic interfacial bonding, biaxial buckling, and wet‐adhesive hydrogels. In situ‐generated Ag–O coordination of silver nanoparticles (AgNPs) in the polymer matrix/conductor dissipates stress and suppresses crack propagation, effectively compensating for AgMF rigidity and enabling intact buckled microstructures. The resulting electrodes exhibit high conductivity (∼2.1 × 10 4 S cm −1 ) and stable resistance under 50% cyclic strain, exceeding cardiac motion requirements (15%–20%). The ink is 3D‐printable into mesh electrodes and can be integrated with wet‐adhesive hydrogels to form puncture‐free, stretchable metallic cardiac bioelectrodes with excellent biosafety, offering a promising route toward leadless pacemakers and long‐term wireless cardiac monitoring. A multiscale synergistic strategy integrating metal‐organic interfacial bonding with stretch‐release‐induced buckled architectures enables silver microflake conductors with simultaneously high conductivity and large deformability, demonstrated for 3D printing of bioadaptive, puncture‐free cardiac electrodes and stretchable wireless coils for dynamic cardiac stimulation and long‐term electrophysiological monitoring.
- 20 November 2026
- Published by Wiley in Advanced Materials
Buckled Silver Microflake Conductors With In Situ‐Generated Ag–O Coordination Enable 3D‐Printed Stretchable Cardiac Bioelectrodes
Metallic pacemaker electrodes risk myocardial injury during implantation, while silver micro‐flakes (AgMFs), despite excellent conductivity, are too rigid for stretchable devices without proper composite/device engineering. Here, we present a synergistic strategy to fabricate fully stretchable, electrically stable, and crack‐resistant cardiac electrodes by integrating AgMF‐based ink with metal‐organic interfacial bonding, biaxial buckling, and wet‐adhesive hydrogels. In situ‐generated Ag–O coordination of silver nanoparticles (AgNPs) in the polymer matrix/conductor dissipates stress and suppresses crack propagation, effectively compensating for AgMF rigidity and enabling intact buckled microstructures. The resulting electrodes exhibit high conductivity (∼2.1 × 10 4 S cm −1 ) and stable resistance under 50% cyclic strain, exceeding cardiac motion requirements (15%–20%). The ink is 3D‐printable into mesh electrodes and can be integrated with wet‐adhesive hydrogels to form puncture‐free, stretchable metallic cardiac bioelectrodes with excellent biosafety, offering a promising route toward leadless pacemakers and long‐term wireless cardiac monitoring. A multiscale synergistic strategy integrating metal‐organic interfacial bonding with stretch‐release‐induced buckled architectures enables silver microflake conductors with simultaneously high conductivity and large deformability, demonstrated for 3D printing of bioadaptive, puncture‐free cardiac electrodes and stretchable wireless coils for dynamic cardiac stimulation and long‐term electrophysiological monitoring.
- Open Access
- 14 November 2026
- Published by MDPI AG in Journal of Cardiovascular Development and Disease
- Vol. 13 (11) , 595
Development and Temporal Validation of a Nomogram to Predict Actionable Arrhythmias During Implantable Cardiac Monitoring in Patients with Unexplained Syncope
Prediction tools for actionable arrhythmias after implantable cardiac monitor (ICM) implantation in patients with unexplained syncope remain limited. This dual-center retrospective study included 302 patients divided chronologically into development (n = 91) and temporal validation (n = 211) cohorts. The endpoint was the first ICM-detected arrhythmia prompting permanent pacemaker or defibrillator implantation, catheter ablation, initiation of Vaughan Williams Class I or III antiarrhythmic drugs, or oral anticoagulation. A multivariable Cox model was developed and internally validated using 1000 bootstrap resamples, repeating variable selection and model fitting. During a median follow-up of 23.4 months, 78 patients reached the endpoint, including 32 in the development cohort and 46 in the temporal validation cohort. The nomogram included age, a history of recurrent syncope, and first-degree atrioventricular block. The optimism-corrected C-index was 0.720 in development. In temporal validation, the C-index was 0.707 (95% confidence interval, 0.623–0.790), and the 12- and 24-month time-dependent areas under the receiver operating characteristic curve were 0.733 and 0.741, respectively. The nomogram showed moderate discrimination in temporal validation at the same two centers. The model underestimated risk at 12 months, whereas mean predicted risk was closer to observed risk at 24 months.
- 14 November 2026
- Published by MDPI AG in Journal of Cardiovascular Development and Disease
- Vol. 13 (11) , 595
Open AccessDevelopment and Temporal Validation of a Nomogram to Predict Actionable Arrhythmias During Implantable Cardiac Monitoring in Patients with Unexplained Syncope
Prediction tools for actionable arrhythmias after implantable cardiac monitor (ICM) implantation in patients with unexplained syncope remain limited. This dual-center retrospective study included 302 patients divided chronologically into development (n = 91) and temporal validation (n = 211) cohorts. The endpoint was the first ICM-detected arrhythmia prompting permanent pacemaker or defibrillator implantation, catheter ablation, initiation of Vaughan Williams Class I or III antiarrhythmic drugs, or oral anticoagulation. A multivariable Cox model was developed and internally validated using 1000 bootstrap resamples, repeating variable selection and model fitting. During a median follow-up of 23.4 months, 78 patients reached the endpoint, including 32 in the development cohort and 46 in the temporal validation cohort. The nomogram included age, a history of recurrent syncope, and first-degree atrioventricular block. The optimism-corrected C-index was 0.720 in development. In temporal validation, the C-index was 0.707 (95% confidence interval, 0.623–0.790), and the 12- and 24-month time-dependent areas under the receiver operating characteristic curve were 0.733 and 0.741, respectively. The nomogram showed moderate discrimination in temporal validation at the same two centers. The model underestimated risk at 12 months, whereas mean predicted risk was closer to observed risk at 24 months.
- Open Access
- 21 September 2026
- Published by Oxford University Press (OUP) in European Heart Journal - Case Reports
- Vol. 10 (10) , ytag718
TRPM4 -related left bundle branch block-induced cardiomyopathy reversed by left bundle branch area pacing-based cardiac resynchronization therapy: a case report
Background: Progressive cardiac conduction disease (PCCD) is a rare inherited disorder characterized by degeneration of the His–Purkinje system. Although primarily considered an electrical disease, chronic left bundle branch block (LBBB) may result in mechanical dyssynchrony and reversible cardiomyopathy. Case summary: A 59-year-old man presented with progressive left ventricular (LV) dilation and systolic dysfunction. Electrocardiography showed complete LBBB with a QRS duration of 165 ms. Ischaemic and infiltrative cardiomyopathies were ruled out. Cardiac magnetic resonance imaging revealed LV enlargement without late gadolinium enhancement but with marked mechanical dyssynchrony. Genetic testing identified a likely pathogenic TRPM4 c.393G>C variant, considered contributory to the conduction phenotype. LBBB-induced cardiomyopathy and heart failure with reduced ejection fraction were diagnosed. The patient underwent left bundle branch area pacing (LBBAP)-based cardiac resynchronization therapy. The QRS duration narrowed to 115 ms, and follow-up echocardiography demonstrated marked reverse remodelling with LV ejection fraction improving from 26% to 48%. Discussion: This case suggests that TRPM4-related PCCD may present with isolated LBBB leading to dyssynchrony-mediated cardiomyopathy. LBBAP can effectively restore electrical synchrony and promote reverse LV remodelling. This favourable response highlights the importance of timely physiological resynchronization in potentially reversible LBBB-related cardiomyopathy.
- 21 September 2026
- Published by Oxford University Press (OUP) in European Heart Journal - Case Reports
- Vol. 10 (10) , ytag718
Open AccessTRPM4 -related left bundle branch block-induced cardiomyopathy reversed by left bundle branch area pacing-based cardiac resynchronization therapy: a case report
Background: Progressive cardiac conduction disease (PCCD) is a rare inherited disorder characterized by degeneration of the His–Purkinje system. Although primarily considered an electrical disease, chronic left bundle branch block (LBBB) may result in mechanical dyssynchrony and reversible cardiomyopathy. Case summary: A 59-year-old man presented with progressive left ventricular (LV) dilation and systolic dysfunction. Electrocardiography showed complete LBBB with a QRS duration of 165 ms. Ischaemic and infiltrative cardiomyopathies were ruled out. Cardiac magnetic resonance imaging revealed LV enlargement without late gadolinium enhancement but with marked mechanical dyssynchrony. Genetic testing identified a likely pathogenic TRPM4 c.393G>C variant, considered contributory to the conduction phenotype. LBBB-induced cardiomyopathy and heart failure with reduced ejection fraction were diagnosed. The patient underwent left bundle branch area pacing (LBBAP)-based cardiac resynchronization therapy. The QRS duration narrowed to 115 ms, and follow-up echocardiography demonstrated marked reverse remodelling with LV ejection fraction improving from 26% to 48%. Discussion: This case suggests that TRPM4-related PCCD may present with isolated LBBB leading to dyssynchrony-mediated cardiomyopathy. LBBAP can effectively restore electrical synchrony and promote reverse LV remodelling. This favourable response highlights the importance of timely physiological resynchronization in potentially reversible LBBB-related cardiomyopathy.
- Open Access
- 11 July 2026
- Published by Springer Nature in Diabetology & Metabolic Syndrome
- Vol. 18 (1) , 178
Comparison of CTI and its modified indices in predicting cardiovascular disease risk across different glycemic statuses: a nationwide prospective cohort study
The C-reactive protein–triglyceride glucose index (CTI) has emerged as a promising composite biomarker for cardiovascular disease (CVD) risk. However
- 11 July 2026
- Published by Springer Nature in Diabetology & Metabolic Syndrome
- Vol. 18 (1) , 178
Open AccessComparison of CTI and its modified indices in predicting cardiovascular disease risk across different glycemic statuses: a nationwide prospective cohort study
The C-reactive protein–triglyceride glucose index (CTI) has emerged as a promising composite biomarker for cardiovascular disease (CVD) risk. However
- Open Access
- 26 May 2026
- Published by Springer Nature in BMC Cardiovascular Disorders
- Vol. 26 (1)
Stress hyperglycemia ratio improves 28-day mortality prediction beyond GRACE score in critically ill patients with acute coronary syndrome: a retrospective cohort study from MIMIC-IV
The stress hyperglycemia ratio (SHR) is increasingly recognized as a reliable biomarker for adverse outcomes. However, its prognostic value specifically fo
- 26 May 2026
- Published by Springer Nature in BMC Cardiovascular Disorders
- Vol. 26 (1)
Open AccessStress hyperglycemia ratio improves 28-day mortality prediction beyond GRACE score in critically ill patients with acute coronary syndrome: a retrospective cohort study from MIMIC-IV
The stress hyperglycemia ratio (SHR) is increasingly recognized as a reliable biomarker for adverse outcomes. However, its prognostic value specifically fo
- 13 May 2026
- Published by Elsevier in International Journal of Cardiology
- Vol. 457, 134541
Corrigendum to “Analysis of the diagnostic value of pre-event intracardiac electrogram (pre-EGM) storage function in cardiac electronic implantable devices for arrhythmia diagnosis” [International Journal of Cardiology 442 (2026) 133881]
- 13 May 2026
- Published by Elsevier in International Journal of Cardiology
- Vol. 457, 134541
Corrigendum to “Analysis of the diagnostic value of pre-event intracardiac electrogram (pre-EGM) storage function in cardiac electronic implantable devices for arrhythmia diagnosis” [International Journal of Cardiology 442 (2026) 133881]
- 4 May 2026
- Published by Wiley in Diabetes, Obesity and Metabolism
- Vol. 28 (7) , 6254-6264
Higher Appendicular Skeletal Muscle Mass to Visceral Fat Area Ratio Associated With Reduced Risk of Prediabetes
Background: The appendicular skeletal muscle mass to visceral fat area ratio (SVR) reflects the interplay between muscle mass and fat distribution and is increasingly recognized as an indicator of metabolic health. However, its association with prediabetes remains unclear. Therefore, this study aimed to investigate the relationship between SVR and prediabetes. Methods: Data from 4195 participants in the 2011–2018 National Health and Nutrition Examination Survey (NHANES) were analysed using a cross‐sectional design. Weighted logistic regression and restricted cubic splines (RCS) were applied to assess the association between SVR and prediabetes. The diagnostic performance of SVR versus body mass index (BMI) and muscle‐to‐fat ratio (MFR) was compared using weighted receiver operating characteristic curves. Mediation analysis was performed to explore potential indirect associations. Results: Higher SVR was significantly associated with reduced risk of prediabetes (adjusted OR 0.24; 95% CI: 0.19–0.31). SVR exhibited a nonlinear relationship with prediabetes, with the inflection point of 0.334 kg/cm 2 for males and 0.199 kg/cm 2 for females. Notably, SVR demonstrated superior diagnostic performance compared to BMI and MFR, with an area under the curve of 0.653, 0.614 and 0.605 in males and 0.689, 0.651 and 0.619 in females, respectively. Moreover, SVR appeared to be more strongly associated with isolated impaired glucose tolerance than with isolated impaired fasting glucose, consistent with its stronger inverse association with 2‐h oral glucose tolerance test glucose ( β = −0.44, 95% CI: −0.52 to −0.36) than with fasting glucose ( β = −0.12, 95% CI: −0.14 to −0.10). Mediation analysis indicated that homeostatic model assessment for insulin resistance explained 51.08% of the total association. Conclusion: SVR showed a significant nonlinear association with prediabetes, with gender‐specific diagnostic thresholds. Moreover, it demonstrated superior diagnostic capability compared to BMI and MFR for identifying prediabetes.
- 4 May 2026
- Published by Wiley in Diabetes, Obesity and Metabolism
- Vol. 28 (7) , 6254-6264
Higher Appendicular Skeletal Muscle Mass to Visceral Fat Area Ratio Associated With Reduced Risk of Prediabetes
Background: The appendicular skeletal muscle mass to visceral fat area ratio (SVR) reflects the interplay between muscle mass and fat distribution and is increasingly recognized as an indicator of metabolic health. However, its association with prediabetes remains unclear. Therefore, this study aimed to investigate the relationship between SVR and prediabetes. Methods: Data from 4195 participants in the 2011–2018 National Health and Nutrition Examination Survey (NHANES) were analysed using a cross‐sectional design. Weighted logistic regression and restricted cubic splines (RCS) were applied to assess the association between SVR and prediabetes. The diagnostic performance of SVR versus body mass index (BMI) and muscle‐to‐fat ratio (MFR) was compared using weighted receiver operating characteristic curves. Mediation analysis was performed to explore potential indirect associations. Results: Higher SVR was significantly associated with reduced risk of prediabetes (adjusted OR 0.24; 95% CI: 0.19–0.31). SVR exhibited a nonlinear relationship with prediabetes, with the inflection point of 0.334 kg/cm 2 for males and 0.199 kg/cm 2 for females. Notably, SVR demonstrated superior diagnostic performance compared to BMI and MFR, with an area under the curve of 0.653, 0.614 and 0.605 in males and 0.689, 0.651 and 0.619 in females, respectively. Moreover, SVR appeared to be more strongly associated with isolated impaired glucose tolerance than with isolated impaired fasting glucose, consistent with its stronger inverse association with 2‐h oral glucose tolerance test glucose ( β = −0.44, 95% CI: −0.52 to −0.36) than with fasting glucose ( β = −0.12, 95% CI: −0.14 to −0.10). Mediation analysis indicated that homeostatic model assessment for insulin resistance explained 51.08% of the total association. Conclusion: SVR showed a significant nonlinear association with prediabetes, with gender‐specific diagnostic thresholds. Moreover, it demonstrated superior diagnostic capability compared to BMI and MFR for identifying prediabetes.
- 8 February 2026
- Published by Springer Nature in Internal and Emergency Medicine
- Vol. 21 (3) , 993-1009
Global trends and projections in cardiovascular disease-related heart failure, 1990–2050: an analysis of the Global Burden of Disease 2021 data
Heart failure (HF) is a major endpoint of cardiovascular disease (CVD) and a growing global public health challenge. This study assessed the global burden of CVD-related HF from 1990 to 2021 and projected trends to 2050. Utilizing data from the Global Burden of Disease (GBD) 2021 study, we analyzed years lived with disability (YLD) and prevalence for CVD-related HF, stratified by sex, age, socio-demographic index (SDI), region, and specific CVD etiology. In 2021, CVD-related HF affected approximately 45.56 million individuals globally, causing 4.32 million YLD. The global age-standardized prevalence and YLD rates were 548.81 and 52.00 per 100,000 population, respectively, with higher rates in males. Hypertensive and ischemic heart disease were predominant causes, except in the under-20 age group where cardiomyopathy/myocarditis and rheumatic heart disease prevailed. From 1990 to 2021, global age-standardized prevalence and YLD rates increased, with the sharpest rise in the 20–54 age group, males and middle to high–middle SDI countries. Age-standardized prevalence and YLD rates declined for rheumatic heart disease, stroke, and non-rheumatic valvular heart disease-related HF, whereas most other etiologies exhibited upward trends, most notably atrial fibrillation/flutter and endocarditis. There were significant disparities in various CVD-related HF across sex, age, SDI country, and region in 2021 and from 1990 to 2021. By 2050, projections indicate that CVD-related HF will increase to varying degrees across sex, age, and specific CVD types. The global burden of CVD-related HF is substantial, escalating, and characterized by significant disparities across sex, age, SDI country, region, and CVD type. Urgent and targeted public health strategies are essential to mitigate this rising burden.
- 8 February 2026
- Published by Springer Nature in Internal and Emergency Medicine
- Vol. 21 (3) , 993-1009
Global trends and projections in cardiovascular disease-related heart failure, 1990–2050: an analysis of the Global Burden of Disease 2021 data
Heart failure (HF) is a major endpoint of cardiovascular disease (CVD) and a growing global public health challenge. This study assessed the global burden of CVD-related HF from 1990 to 2021 and projected trends to 2050. Utilizing data from the Global Burden of Disease (GBD) 2021 study, we analyzed years lived with disability (YLD) and prevalence for CVD-related HF, stratified by sex, age, socio-demographic index (SDI), region, and specific CVD etiology. In 2021, CVD-related HF affected approximately 45.56 million individuals globally, causing 4.32 million YLD. The global age-standardized prevalence and YLD rates were 548.81 and 52.00 per 100,000 population, respectively, with higher rates in males. Hypertensive and ischemic heart disease were predominant causes, except in the under-20 age group where cardiomyopathy/myocarditis and rheumatic heart disease prevailed. From 1990 to 2021, global age-standardized prevalence and YLD rates increased, with the sharpest rise in the 20–54 age group, males and middle to high–middle SDI countries. Age-standardized prevalence and YLD rates declined for rheumatic heart disease, stroke, and non-rheumatic valvular heart disease-related HF, whereas most other etiologies exhibited upward trends, most notably atrial fibrillation/flutter and endocarditis. There were significant disparities in various CVD-related HF across sex, age, SDI country, and region in 2021 and from 1990 to 2021. By 2050, projections indicate that CVD-related HF will increase to varying degrees across sex, age, and specific CVD types. The global burden of CVD-related HF is substantial, escalating, and characterized by significant disparities across sex, age, SDI country, region, and CVD type. Urgent and targeted public health strategies are essential to mitigate this rising burden.
- Open Access
- 10 September 2025
- Published by Wiley in The Journal of Clinical Hypertension
- Vol. 27 (9) , e70109
Burden of Disease Attributable to High Systolic Blood Pressure in Young Adults: An Analysis From the Global Burden of Disease Study 2021
This study aims to fill this gap by leveraging Global Burden of Disease 2021 (GBD 2021) data to conduct a comprehensive assessment of the disease burden attributable to high systolic blood pressure (SBP) in young adults. Data from the Global Health Data Exchange were utilized to estimate the disease burden attributable to high SBP in young adults, stratified by overall disease, sex, socio‐demographic index (SDI) level, GBD region, nation, and specific disease. In 2021, the overall disease attributable to high SBP in young adults was substantial, with approximately 24,626,362 disability‐adjusted life years (DALYs) and 477,992 deaths, and the DALYs and mortality rates were 623.68 and 12.11 per 100,000 populations, respectively. The DALYs and mortality rates of specific disease were highest for ischemic heart disease (IHD), followed by intracerebral hemorrhage (ICH), and hypertensive heart disease (HHD). From 1990 to 2021, the DALYs and mortality rates for overall disease attributable to high SBP in young adults showed no significant change.However, there were greater declines in HHD and ICH, while the majority of diseases exhibited an upward trend. The DALYs and mortality rates for overall disease attributable to high SBP in young adults showed no significant change in females but increased in males. The SDI regions like middle and low‐middle SDI regions, GBD regions like Oceania and Caribbean, and countries like Lesotho and Zimbabwe presented the largest increases in the DALYs and mortality rates for overall disease attributable to high SBP in young adults. The trends for certain diseases attributable to high SBP in young adults, when analyzed by sex, SDI level, and region, diverge from the overall disease trends. This study highlights the significant overall disease burden attributable to high SBP in young adults. Despite an overall steady trend in the DALYs and mortality rates since 1990, significant disparities persist across overall diseases, sexes, SDI levels, regions, countries, and specific diseases. These disparities highlight the need for strategic interventions to reduce the health impact of high SBP in young adults.
- 10 September 2025
- Published by Wiley in The Journal of Clinical Hypertension
- Vol. 27 (9) , e70109
Open AccessBurden of Disease Attributable to High Systolic Blood Pressure in Young Adults: An Analysis From the Global Burden of Disease Study 2021
This study aims to fill this gap by leveraging Global Burden of Disease 2021 (GBD 2021) data to conduct a comprehensive assessment of the disease burden attributable to high systolic blood pressure (SBP) in young adults. Data from the Global Health Data Exchange were utilized to estimate the disease burden attributable to high SBP in young adults, stratified by overall disease, sex, socio‐demographic index (SDI) level, GBD region, nation, and specific disease. In 2021, the overall disease attributable to high SBP in young adults was substantial, with approximately 24,626,362 disability‐adjusted life years (DALYs) and 477,992 deaths, and the DALYs and mortality rates were 623.68 and 12.11 per 100,000 populations, respectively. The DALYs and mortality rates of specific disease were highest for ischemic heart disease (IHD), followed by intracerebral hemorrhage (ICH), and hypertensive heart disease (HHD). From 1990 to 2021, the DALYs and mortality rates for overall disease attributable to high SBP in young adults showed no significant change.However, there were greater declines in HHD and ICH, while the majority of diseases exhibited an upward trend. The DALYs and mortality rates for overall disease attributable to high SBP in young adults showed no significant change in females but increased in males. The SDI regions like middle and low‐middle SDI regions, GBD regions like Oceania and Caribbean, and countries like Lesotho and Zimbabwe presented the largest increases in the DALYs and mortality rates for overall disease attributable to high SBP in young adults. The trends for certain diseases attributable to high SBP in young adults, when analyzed by sex, SDI level, and region, diverge from the overall disease trends. This study highlights the significant overall disease burden attributable to high SBP in young adults. Despite an overall steady trend in the DALYs and mortality rates since 1990, significant disparities persist across overall diseases, sexes, SDI levels, regions, countries, and specific diseases. These disparities highlight the need for strategic interventions to reduce the health impact of high SBP in young adults.